Home Ironwood Pharmaceuticals Initiates Phase III Trial Of 72 mcg Linaclotide In Adult Patients With Chronic Idiopathic Constipation
 

Keywords :   


Ironwood Pharmaceuticals Initiates Phase III Trial Of 72 mcg Linaclotide In Adult Patients With Chronic Idiopathic Constipation

2014-11-05 05:57:43| drugdiscoveryonline Home Page

Ironwood Pharmaceuticals, Inc. announced recently the initiation of a Phase III clinical trial in the U.S. evaluating a 72 mcg capsule of linaclotide to be taken once per day for the treatment of adults suffering from chronic idiopathic constipation (CIC)

Tags: iii trial adult phase

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
24.1120225//
24.112012()
24.11oasis 2022 morning
24.11Bianchi San marco xr3
24.11()
24.11PS2
24.11
24.11 HD DVD BOX
More »